Release Date: 15/11/18 11:51 Summary: Results of Annual General Meeting Price Sensitive: No Download Document 226.63KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%